PMID- 14671251 OWN - NLM STAT- MEDLINE DCOM- 20040126 LR - 20161122 IS - 1524-4628 (Electronic) IS - 0039-2499 (Linking) VI - 35 IP - 1 DP - 2004 Jan TI - Decreased levels of plasma vitamin C and increased concentrations of inflammatory and oxidative stress markers after stroke. PG - 163-8 AB - BACKGROUND AND PURPOSE: Inflammatory response is a critical component of the complex pathophysiological response to stroke. Vitamin C has been shown to have important roles in cell performance and vascular function. In this study, we compared the nutritional status and levels of inflammatory markers between stroke cases and controls and assessed which antioxidant was associated with levels of inflammatory markers and oxidative stress among cases and controls. METHODS: We evaluated the nutritional status and measured plasma levels of vitamins C and E, uric acid, serum levels of C-reactive protein (CRP), the cytokines tumor necrosis factor-alpha and interleukin-1beta, intercellular adhesion molecule-1 (ICAM-1) and chemokine monocyte chemoattractant protein-1 (MCP-1), prostaglandins PGE2 and PGI2, and 8-isoprostanes (8-epiPGF2alpha) for 15 patients with ischemic stroke within 2 to 5 days after stroke onset and for 24 control subjects. RESULTS: Stroke patients had significantly lower plasma levels of vitamin C than did controls. Among stroke patients, CRP was significantly elevated, as were the ICAM-1, MCP-1, and 8-epiPGF2alpha, but the prostaglandins PGE2 and PGI2 were significantly reduced. Interestingly, vitamin C concentration was significantly inversely correlated with the levels of CRP and 8-epiPGF2alpha among stroke patients, and 8-epiPGF2alpha was significantly associated with the levels of CRP. Uric acid was also elevated among stroke patients. CONCLUSIONS: Lower vitamin C concentration, higher serum levels of inflammatory (CRP, ICAM-1, MCP-1) and oxidative stress (8-epiPGF2alpha) markers, and lower PGI2 and PGE2 concentrations among stroke patients indicate the presence of an inflammatory response associated with stroke. FAU - Sanchez-Moreno, Concepcion AU - Sanchez-Moreno C AD - Nutrition and Neurocognition Laboratory, Jean Mayer USDA-Human Nutrition Research Center on Aging, Boston, Mass 02111, USA. FAU - Dashe, John F AU - Dashe JF FAU - Scott, Tammy AU - Scott T FAU - Thaler, David AU - Thaler D FAU - Folstein, Marshal F AU - Folstein MF FAU - Martin, Antonio AU - Martin A LA - eng PT - Clinical Trial PT - Controlled Clinical Trial PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20031211 PL - United States TA - Stroke JT - Stroke JID - 0235266 RN - 0 (Antioxidants) RN - 0 (Biomarkers) RN - 0 (Chemokine CCL2) RN - 0 (Cytokines) RN - 0 (Inflammation Mediators) RN - 0 (Prostaglandins) RN - 126547-89-5 (Intercellular Adhesion Molecule-1) RN - 1406-18-4 (Vitamin E) RN - 268B43MJ25 (Uric Acid) RN - 27415-26-5 (8-epi-prostaglandin F2alpha) RN - 9007-41-4 (C-Reactive Protein) RN - B7IN85G1HY (Dinoprost) RN - PQ6CK8PD0R (Ascorbic Acid) SB - IM MH - Aged MH - Antioxidants/analysis MH - Ascorbic Acid/*blood MH - Biomarkers/blood MH - Brain Ischemia/*blood/complications MH - C-Reactive Protein/analysis MH - Chemokine CCL2/blood MH - Cytokines/blood MH - Diet MH - Dinoprost/*analogs & derivatives/blood MH - Humans MH - Inflammation Mediators/*blood MH - Intercellular Adhesion Molecule-1/blood MH - Middle Aged MH - Neuropsychological Tests MH - Nutritional Status MH - *Oxidative Stress MH - Prostaglandins/blood MH - Reference Values MH - Stroke/*blood/complications MH - Time Factors MH - Uric Acid/blood MH - Vitamin E/blood EDAT- 2003/12/13 05:00 MHDA- 2004/01/27 05:00 CRDT- 2003/12/13 05:00 PHST- 2003/12/13 05:00 [pubmed] PHST- 2004/01/27 05:00 [medline] PHST- 2003/12/13 05:00 [entrez] AID - 01.STR.0000105391.62306.2E [pii] AID - 10.1161/01.STR.0000105391.62306.2E [doi] PST - ppublish SO - Stroke. 2004 Jan;35(1):163-8. doi: 10.1161/01.STR.0000105391.62306.2E. Epub 2003 Dec 11.